Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by gebremeskelon Dec 14, 2016 12:48pm
142 Views
Post# 25599037

RE:So excuse me

RE:So excuse meThis is also what I also understood from the video.

This trial is meant to demonstrate a reduction of recurrence of cancer after the front line treatments have been undergone..

Non-muscle-invasive bladder cancer has a high rate of recurrence.

The use of the Theralase procedure as a front line treatment for cancer would involve another clinical trial.

 
woundedknee wrote: I guess I didn't get my question answered earlier. In the rodent tests I believe the results were aimed directly at the complete tumor. In this video I believe I understood the Doctor to say we only use our procedure after a scraping of the tumors on the bladder which has not yet gone into the muscle. I may have misunderstood him. but I believed he said that this trial was not approved for a treatment of the complete tumor. Could someone clarify this for me? TIA


Bullboard Posts